University of Maryland
Marlene and Stewart Greenebaum Cancer Center
Kevin J. Cullen, M.D.
22 South Greene Street
Baltimore, Maryland 21201
Tel: (410) 328-5506
Fax: (410) 328-2578
Information on University of Maryland Greenebaum Cancer Center
The University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) has a long and rich history of cancer research, patient care and medical education throughout the state of Maryland and the Mid-Atlantic region. Located on the medical campus of the University of Maryland at Baltimore, the Center is part of both the University of Maryland Medical Center and the University of Maryland School of Medicine. All of the center’s researchers and physicians are on the faculty of the medical school and other professional schools at the University of Maryland, Baltimore. The center was named in honor of real estate developer and businessman Stewart Greenebaum and his wife, Marlene, a breast cancer survivor.
The mission of the UMGCC is to undertake innovative basic and clinical research that will impact the understanding and treatment of cancer around the world and to provide state–of–the–art clinical care to cancer patients in Maryland and beyond. We conduct an interactive, multidisciplinary research program focusing on the rapid transfer of knowledge from the laboratory to the clinic. We have developed a national and international reputation as an institution with expertise in laboratory and clinical research providing new approaches to cancer treatment. Research performed at the UMGCC has had a significant impact on cancer care worldwide, particularly the pioneering work of Dr. Angela Brodie for the development of aromatase inhibitors for the treatment of breast cancer.
Our goal is to take advantage of discoveries in basic cancer biology in conjunction with clinical research to: develop and apply innovative cancer treatment and prevention strategies; describe the molecular mechanisms underlying specific clinical phenotypes and behaviors; and apply these discoveries and strategies to the Maryland community and beyond, with a specific focus on cancer disparities.

The NCI Cancer Centers Program was set up to help advance scientific research into the causes and treatment of cancer. It recognizes those centers that are actively engaged in conducting research into ways to reduce the incidence and impact of cancer in their communities. The designation comes with very stringent requirements about the quality of a center’s scientific research. It is the ultimate “seal of approval,” if you will, for cancer centers nationwide.

We are one of only 64 cancer centers in the country that have achieved this distinction. So, to be recognized in this way is a tremendous honor and achievement for us. It means that UMGCC is one of the top cancer centers in the United States.

Make an appointment

Either you, a family member or referring physician may schedule an appointment by calling our Patient Referral Office at 410-328-7904, between 8:00 a.m. and 4:30 p.m. Monday through Friday. Out-of-town callers may use our toll free number, 1-800-888-8823.

When you call, please be prepared to provide the following information:

  • Patient’s full name, address, phone number, date of birth and social security number
  • Fax or e-mail address, if you prefer these communication options
  • Diagnosis and date of diagnosis
  • Source of referral: physician, friend/relative, hotline, Internet, self, other
  • Name, phone number and fax number of your primary care and/or any referring physician
  • Insurance company name and identification number
  • Preference for a specific physician or appointment date
  • Name and phone number of a contact person

Find a doctor

*Source: National Cancer Institute

Leave a Comment